Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	29871
Country	United States

Received	2016-08-30 09:10
Peer-Review Started	2016-09-01 09:46
To Make the First Decision	2016-09-26 12:05
Return for Revision	2016-09-29 14:39
Revised	2016-10-13 09:59
Second Decision	2016-12-06 10:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-12-14 17:20
Articles in Press	2016-12-14 17:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-01-12 17:31
Publish the Manuscript Online	2017-01-20 16:40

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Gurshawn Singh, Ammar Nassri, David Kim, Hong Zhu and Zeeshan Ramzan
Funding Agency and Grant Number
Corresponding Author	Zeeshan Ramzan, MD, Assistant Professor, Gastrointestinal Section, Department of Internal Medicine, VA North Texas Healthcare System, 4500 South Lancas­ter Rd, Dallas, TX 75216, United States. zeeshanramzan@hotmail.com
Key Words	Prognosis; Lymphocyte-to-monocyte ratio; Pancreatic adenocarcinoma; Mortality; Biomarker
Core Tip	Pancreatic adenocarcinoma is an aggressive malignancy and many patients are presented with aggressive treatment options at diagnosis; often times they are unsure whether they should take a palliative route or a more aggressive approach to their care. Through a retrospective analysis of patients with pan-creatic adenocarcinoma, we found that a higher lympho-cyte-to-monocyte ratio is associated with improved survival. The lymphocyte-to-monocyte ratio was collect-ed at diagnosis, and is readily available on routine blood work, making it a simple way to help predict and guide treatment in patients diagnosed with pancreatic adenocarcinoma.
Publish Date	2017-01-20 16:40
Citation	Singh G, Nassri A, Kim D, Zhu H, Ramzan Z. Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adeno­car­cinoma. World J Gastrointest Pharmacol Ther 2017; 8(1): 60-66
URL	http://www.wjgnet.com/2150-5349/full/v8/i1/60.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v8.i1.60

Full Article (PDF)	WJGPT-8-60.pdf
Full Article (Word)	WJGPT-8-60.doc
Manuscript File	29871-Review.docx
Answering Reviewers	29871-Answering reviewers.pdf
Audio Core Tip	29871-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	29871-Conflict-of-interest statement.pdf
Copyright License Agreement	29871-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	29871-Institutional review board statement.pdf
Peer-review Report	29871-Peer-review(s).pdf
Scientific Misconduct Check	29871-Scientific misconduct check.pdf
Scientific Editor Work List	29871-Scientific editor work list.pdf